• Salmonella Haem Biosynthesis Inhibits Macrophage Phagocytosi

  2026-08-05

  The referenced study reveals a methyltransferase-driven mechanism by which Salmonella Typhimurium enhances haem production, inhibiting macrophage phagocytosis and promoting bacterial virulence. These findings clarify the link between bacterial haem biosynthesis and immune evasion, offering new strategies for infectious disease modeling and heme pathway research.

• CTCF-FLG-AS1 Axis Drives Macrophage Reprogramming in PDAC

  2026-08-04

  This study uncovers how CTCF promotes pancreatic ductal adenocarcinoma (PDAC) progression through FLG-AS1-dependent epigenetic regulation and reprogramming of tumor-associated macrophages. The findings reveal intricate mechanisms involving histone lactylation, m6A modification, and alternative splicing, highlighting CTCF as a promising immunotherapeutic target in PDAC.

• Applied Neurotensin Workflows for GPCR Trafficking Studies

  2026-08-04

  Neurotensin (CAS 39379-15-2) empowers researchers to precisely dissect Neurotensin receptor 1-mediated signaling, with validated workflows for GPCR trafficking and miRNA regulation. This guide delivers practical protocols, troubleshooting insights, and a translation of cutting-edge spectral interference removal for reproducible gastrointestinal and neural cell assays.

• Fosinopril Sodium: ACE Inhibitor Workflows in Hypertension R

  2026-08-03

  Fosinopril sodium offers unique dual renal-hepatic elimination and potent ACE inhibition for advanced hypertension and cardiovascular disease models. This article delivers actionable protocols, troubleshooting tips, and comparative insights to enhance experimental reproducibility and translational value in blood pressure research.

• Br-DAPI: High-Sensitivity DAPI Fluorescent Dye for DNA Stain

  2026-08-03

  Br-DAPI from APExBIO sets a new standard for DNA quantification in both live and fixed cells, delivering robust 20-fold fluorescence amplification and exceptional selectivity for A/T-rich DNA. This next-generation DAPI fluorescent dye streamlines imaging workflows, especially in complex models like diabetic cardiomyopathy, while offering clear troubleshooting advantages over legacy stains.

• Biotin-tyramide: Precision Signal Amplification for Proteomi

  2026-08-02

  Biotin-tyramide delivers exceptional enzyme-mediated signal amplification, unlocking high-sensitivity proximity labeling and interactome mapping in live-cell and tissue workflows. This article unpacks optimized protocols, experimental caveats, and the translational edge of APExBIO’s trusted reagent in advanced IHC, ISH, and spatial proteomics.

• Trypsin (BA5744): Reliable Protease for Cell Assay Precision

  2026-08-01

  Integrating evidence-driven practice, this article addresses core laboratory challenges in cell-based assays using Trypsin (SKU BA5744). We explore protocol optimization, data interpretation, and product selection, highlighting how Trypsin's robust specificity and water solubility foster reproducible results for advanced life science workflows.

• Acetylspiramycin (Spiramycin B) in Advanced Resistance Resea

  2026-07-31

  Acetylspiramycin (Spiramycin B) stands out for its robust activity against macrolide-resistant bacteria and its unique immunomodulatory properties. This article delivers a practical roadmap for optimizing experimental workflows, overcoming common pitfalls, and leveraging genetic advances for cutting-edge antimicrobial resistance research.

• HHV-7 DNA Detection in Ocular Toxoplasmosis: Diagnostic Adva

  2026-07-31

  This case report documents the first detection of human herpesvirus 7 (HHV-7) DNA in the vitreous humor of a patient with recurrent ocular toxoplasmosis, using multiplex PCR. The findings expand the diagnostic landscape for infectious uveitis and highlight the complexity of managing antimicrobial resistance and refractory ocular infections.

• Cisapride (R 51619): Precision Tools for Cardiac Electrophys

  2026-07-30

  Cisapride (R 51619) is redefining cardiac arrhythmia research by enabling high-content, phenotypic screening of iPSC-derived cardiomyocytes and robust hERG channel inhibition assays. This guide unpacks advanced workflows, troubleshooting, and protocol optimizations, empowering researchers to harness APExBIO’s validated compound for reproducible, translational cardiac safety studies.

• Isradipine (Dynacirc): Advanced Neurovascular Research Front

  2026-07-30

  Explore Isradipine (Dynacirc) as a high-purity L-type calcium channel blocker for cutting-edge neuroprotective and vascular smooth muscle research. This article delivers a uniquely integrative analysis of mechanistic insights, protocol parameters, and translational impact.

• Prostaglandin E2 (PGE2) Solutions for Reliable Inflammation

  2026-07-29

  This authoritative guide addresses common laboratory challenges in inflammation research by illustrating how Prostaglandin E2 (SKU B7005) from APExBIO ensures experimental reproducibility, sensitivity, and robust GPCR signaling assays. Scenario-driven Q&A blocks provide actionable insights for biomedical researchers, focusing on validated workflows and literature-backed best practices.

• Doxorubicin in Cancer Research: Protocols, Innovations & Sol

  2026-07-29

  Doxorubicin (Adriamycin) is a foundational chemotherapeutic agent for solid tumors and hematologic malignancy research, enabling precise DNA damage and apoptosis induction in cancer cells. This article decodes advanced workflows, troubleshooting tips, and pivotal findings from recent SMYD2 studies to maximize the impact of APExBIO’s Doxorubicin in experimental oncology.

• PPM-18 as a Precision Tool for iNOS/NF-κB Pathway Modulation

  2026-07-28

  Explore how PPM-18, a potent iNOS expression inhibitor, enables advanced inflammation and sepsis research through selective NF-κB pathway modulation. This in-depth article offers unique assay insights, mechanistic context, and practical guidance distinct from other resources.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-07-28

  This study uncovers a novel mechanism by which HOXC8, a homeobox transcription factor, supports non-small cell lung carcinoma (NSCLC) tumorigenesis by repressing caspase-1 expression and preventing pyroptotic cell death. The findings offer new insight into the epigenetic control of inflammasome-mediated cell death in cancer, with methodological advances facilitating targeted apoptosis and pyroptosis research.

452 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page